UK markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1800-0.1400 (-6.03%)
As of 02:55PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
24,143
15,337
8,021
2,021
2,426
Selling general and administrative
7,572
7,936
7,267
4,955
1,498
Total operating expenses
31,715
23,272
15,286
6,972
3,916
Operating income or loss
-31,715
-23,272
-15,286
-6,972
-3,916
Interest expense
-
0
0.979
78.554
29.48
Total other income/expenses net
18,291
2,079
-11,689
-6,768
-78.901
Income before tax
-12,689
-20,302
-26,839
-13,816
-4,025
Income from continuing operations
-12,689
-20,302
-26,839
-13,816
-4,025
Net income
-12,607
-20,302
-26,839
-13,816
-4,025
Net income available to common shareholders
-12,607
-20,302
-26,839
-13,816
-4,025
Basic EPS
-0.85
-1.30
-1.73
-0.09
-5.64
Diluted EPS
-1.73
-1.30
-1.73
-0.09
-5.64
Basic average shares
15,736
15,620
15,494
4,520
713.889
Diluted average shares
15,909
15,620
15,494
4,520
713.889